Navigation Links
Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
Date:4/26/2010

RESEARCH TRIANGLE PARK, N.C., April 26 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will release its first quarter 2010 financial results on April 28, 2010, after the stock market closes and will host a conference call at 8:30 a.m. Eastern Time on April 29, 2010.

Investors and analysts may participate via phone by calling 1-888-713-4205 (domestic) or 1-617-213-4862 (international), pass code number 21563385. To ensure timely access, please dial into the call approximately 10 minutes before it is scheduled to begin. The listen-only webcast will also be available through the investor relations section of http://www.talecris.com.

Participants may pre-register for the conference call at: https://www.theconferencingservice.com/prereg/key.process?key=PPMXLQM7G. Pre-registrants will be issued a PIN number to use when dialing into the live call, which will provide quick access to the conference by bypassing the operator upon connection.

A replay of the conference call will be available beginning approximately two hours after the call concludes and will remain accessible until May 6, 2010, by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international), pass code number 40214869. The webcast of the conference call will be archived on the investor relations section of http://www.talecris.com.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas, including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.


'/>"/>
SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
2. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
3. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
4. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
5. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
6. Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors
7. Oxford BioTherapeutics Appoints Michael Moore as Chairman
8. Oxygen Biotherapeutics, Inc. Expands Board of Directors
9. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
10. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
11. Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks Associates ... will speak at the TMA 2017 Annual Meeting , October 11 ... in the residential home security market and how smart safety and security ... Parks Associates: ... "The residential security ...
(Date:10/9/2017)... SAN DIEGO , Oct. 9, 2017 /PRNewswire/ ... a biological mechanism by which its ProCell stem ... of critical limb ischemia.  The Company, demonstrated that ... the amount of limbs saved as compared to ... of the molecule HGF resulted in reduction of ...
(Date:10/9/2017)... (PRWEB) , ... October 09, ... ... published on October 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s ... the gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) using ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech ... technology sector at their fourth annual Conference where founders, investors, innovative practitioners and ... the ELEVATE pitch competition showcasing early stage digital health and med tech companies. ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
Breaking Biology News(10 mins):